As we continue our focus on strengthening our research team, we’re pleased to share two new hires have been appointed to lead our new Resources sector coverage: Ben Lyons and...
Jarden Announces Admission as a Market Participant on ASX and Chi-X
Investment and advisory firm Jarden today announced it has been admitted as a Market Participant on ASX and Chi-X Australia, providing clients with more choice and diversity.
Chief Executive of Jarden Australia, Robbie Vanderzeil, said it was a strategic milestone and underlines Jarden’s long-term commitment to Australia.
“It demonstrates our client centric culture, as we deliver an exceptional level of service across the trans-Tasman market. Combined with some of the best talent in Australasian investment banking, the ASX and Chi-X admission delivers a seamless experience for our clients - from the provision of advice to executing trades directly to markets.”
Jarden Australia Chief Operating Officer, Tim Keegan, said the attention to detail of the Jarden in-house team and its advisers was a key factor in promptly establishing Jarden’s market presence in Australia.
“The fact that our first direct trades are being executed today is a testament to the skills of our team, who have worked tirelessly over the past six months to meet all the strict regulatory requirements relating to the ASX and Chi-X admission about governance, policies, procedures and people.”
Having already executed significant volumes of trades on ASX and Chi-X over the last 10 months, Jarden’s admission as an ASX and Chi-X market participant will further accelerate the growth of its Institutional Equities franchise in Australia.
Jarden will use global bank ABN Amro as its clearing and settlements partner.
All media enquiries, please contact:
Adam Szentes | M. 021 265 1067 | [email protected]
News & insights
Balancing oil supply and demand has always been delicate, and even more so with increasing economic activity and easing pandemic restrictions over the last few months.
Quality companies conquer but inflation infiltrates outlooks, says Jarden Australia's Head of Research Ben Gilbert.